Patient lifetime value: how to calculate patient LTV for a cash-pay practice

Every marketing decision you make is a bet: you spend money now to win a patient, and you trust that the patient pays you back over time. Patient lifetime value, or LTV, is the number on the other side of that bet. It is the total profit a typical patient generates across the whole time they stay with you. Get it right and you know exactly how much you can afford to spend to acquire a patient, which channels to keep, and which services are worth building a following around. Get it wrong, usually by counting revenue instead of profit, and you will happily overspend your way into a busy, unprofitable practice.

This is a deep dive on how to calculate LTV for a cash-pay practice, why the revenue-based version most people use is dangerously optimistic, and how LTV pairs with acquisition cost to set your marketing budget. The figures throughout are illustrative, chosen to show how the math behaves. Run every formula against your own prices, costs, and retention before you act on it.

What lifetime value actually means for a cash-pay practice

In a cash-pay practice, there is no insurer setting your reimbursement and no contract locking a patient in. A patient stays because they choose to, visit after visit. That makes LTV a truer measure of the business than it is almost anywhere else: it captures not just what a patient spends once, but whether your results, your cadence, and your follow-up keep them coming back.

The single most important word in the definition is profit, not revenue. LTV is not the total a patient spends with you. It is the gross profit they leave behind after the direct cost of delivering their care: the toxin vial, the syringe of filler, the compounded medication, the lab draw, the device consumable. A patient who spends $10,000 over three years on a service that is mostly pass-through drug cost is worth far less to you than the number suggests. Anchor LTV to contribution, the money left after variable cost, and it becomes a figure you can actually use.

How to calculate patient LTV, step by step

The core formula has three inputs, and each one is a lever you can pull later:

LTV = gross profit per visit x visits per year x years a patient stays

Walk through each input deliberately, because the mistakes almost always hide in the first one:

1. Gross profit per visit. Take the average price of a visit and subtract only the variable cost of delivering it: product, consumables, medication, labs, disposables. Do not subtract rent, salaries, or marketing here. If the average visit bills $300 and costs $120 in product to deliver, gross profit per visit is $180.
2. Visits per year. How often a typical patient actually comes in over a year, not how often they theoretically could. A neurotoxin patient on a natural cadence might come three to four times a year; a laser package patient might come six times in one year and then rarely.
3. Years a patient stays. Your average retention window, in years. This is the input owners guess at most and measure least. If you do not have clean data, estimate it conservatively from your own patient records, then revisit it as you learn.

Put those together with the illustrative numbers above: $180 gross profit per visit, three visits a year, and a patient who stays two and a half years. That is 180 x 3 x 2.5, or an LTV of $1,350. That single number, built from contribution rather than revenue, is what you can reason about when you decide how much to spend to win the next patient.

If you want to sharpen the profit-per-visit input, it is the same contribution logic that drives profit per provider-hour, the metric that measures what an hour of clinical time produces after direct cost. LTV is that per-visit contribution extended across the whole relationship.

Why revenue-based LTV overstates the truth

The most common way to calculate LTV is also the most flattering: take revenue per visit instead of gross profit, multiply by frequency and years, and admire the result. It produces a big, confident number that quietly assumes every dollar a patient spends is a dollar you keep. It is not.

Return to the same illustrative patient. The visit bills $300 and costs $120 in product, so gross margin is 60% and gross profit is $180. The honest LTV is 180 x 3 x 2.5 = $1,350. The revenue-based version uses the full $300: 300 x 3 x 2.5 = $2,250. Same patient, same behavior, but the revenue figure is $900 higher, roughly two-thirds larger than the truth. Base your acquisition budget on $2,250 and you will authorize spend the real $1,350 can never repay.

The gap between revenue-based and profit-based LTV is exactly your cost of goods. In a low-margin, drug-heavy service, that gap is enormous, and it is precisely where revenue-based LTV does the most damage.

This is the same trap that lets a practice grow revenue while profit stalls, covered in why revenue is up but profit is not. Revenue-based LTV is a top-line story dressed up as a profit story. Always use contribution.

LTV against acquisition cost: the ratio that matters

LTV on its own tells you what a patient is worth. It only becomes a decision when you set it against what a patient costs to acquire. Customer acquisition cost, or CAC, is your total sales and marketing spend divided by the new patients it brought in over the same period. Spend $6,000 on a campaign that wins 40 new patients and your CAC is $150.

A common rule of thumb: LTV should be at least 3x CAC.

With the LTV of $1,350 from earlier and a CAC of $150, the ratio is 1,350 divided by 150, or 9 to 1. That is a healthy, even generous, margin of safety, and it usually signals you could afford to spend more aggressively to win patients, not less. A ratio near 3 to 1 is workable but leaves little room for error. A ratio below 1 means every new patient you buy loses money, which is what happens when a discounted intro offer pulls in deal-seekers who never return.

CAC payback period: how fast you get your money back

The ratio tells you whether the bet pays off eventually. CAC payback tells you how long you wait, which matters enormously for cash flow. It is how long it takes a patient's gross profit to repay what you spent to acquire them.

With gross profit of $180 per visit and three visits a year, a patient generates $540 of gross profit annually. Recovering a $150 CAC therefore takes 150 divided by 540, about a quarter of a year, which is less than one visit: the very first appointment at $180 already covers the $150 you spent to win the patient. That is a fast payback, and fast payback is what lets you reinvest in acquisition without straining cash. A practice whose CAC only clears after a full year of visits is running a much riskier marketing program, even if the eventual LTV:CAC looks fine.

Why LTV differs sharply by vertical

LTV is not a fixed property of a cash-pay practice. It is largely determined by the business model of the service, and the spread across verticals is wide. The dividing line is whether the model is recurring or one-off.

Recurring and membership models: high LTV

Programs that patients renew on a schedule produce the highest LTV, because retention is built into the model rather than hoped for. Consider an illustrative hormone or TRT program billed at $199 a month. If the medication, labs, and supplies run about $79 a month, gross profit is $120 a month, or $1,440 a year. A patient who stays three years is worth 1,440 x 3 = $4,320 in gross profit. Concierge and direct primary care memberships behave similarly: a recurring fee, low incremental cost, and multi-year retention stack contribution year after year. The economics of those recurring models are covered in hormone and TRT clinic profitability and whether concierge medicine is profitable.

One-off treatments: low LTV

At the other end, a service a patient buys once, completes, and does not need again produces a thin LTV no matter how good the single-visit margin looks. A completed laser hair removal package or a one-time cosmetic procedure can have an excellent margin per treatment and still generate almost no repeat contribution. For these services, LTV depends entirely on cross-sell: turning that first patient into a neurotoxin regular or a membership member is the only way the relationship keeps paying.

The practical consequence: you can afford a much higher CAC for a recurring-membership patient than for a one-off treatment patient, because the recurring patient repays it many times over. Treating both as if they had the same LTV is how practices overspend to acquire the wrong patients.

The levers that raise LTV

Because LTV is built from three inputs, there are three families of levers to raise it. Notice that most of them cost far less than buying more patients, which is the whole point:

• Retention and rebooking. Extending the years a patient stays is the single most powerful lever, because it multiplies through the whole formula. Booking the next appointment before the patient leaves the room is the cheapest retention tactic there is.
• Visit cadence. Helping patients stay on the clinically appropriate schedule, rather than drifting to once or twice a year, raises visits per year directly. Recall systems and treatment plans do this without any new marketing.
• Cross-sell and add-ons. Introducing a single-service patient to a complementary treatment raises both frequency and gross profit per visit. This is how a one-off patient becomes a recurring one.
• Memberships. Converting occasional patients onto a recurring plan is the most reliable way to lift retention and cadence at once. Priced correctly, a membership turns an unpredictable relationship into a durable one, covered in how to price a membership so it stays profitable.

These are the same durable-profit moves in how to increase profit without more patients, viewed through the lens of one patient over time. Raising LTV and raising profit-per-hour are two views of the same discipline.

How LTV sets what you can spend to acquire a patient

This is where LTV stops being a vanity figure and becomes a budget. If you hold to the 3 to 1 rule of thumb, your maximum sustainable CAC is roughly one-third of LTV. With an LTV of $1,350, that puts a ceiling around $450 per new patient. With the recurring-program LTV of $4,320, the ceiling rises past $1,400, which is why membership-model practices can outbid one-off practices for the same patient and still profit.

Your LTV does not just measure the patients you have. It sets the price you are allowed to pay for the next one.

That reframes the whole growth conversation. A practice that raises LTV, through retention, cadence, cross-sell, and memberships, has not just made each patient more valuable. It has earned the right to spend more to acquire patients, compete for better channels, and grow faster, all without touching its margins. A practice with a thin, revenue-flattered LTV is stuck bidding low and hoping. The number, calculated honestly, is the constraint the entire acquisition strategy has to respect.

See LTV in the context of the whole practice

LTV is one number in a small set that actually decides your take-home. To see where it sits alongside profit per provider-hour, margin, retention, and the rest, read the financial metrics every owner should track, and to sharpen the per-visit profit that drives the whole calculation, start with profit per provider-hour. The Inside Look walks through a complete sample practice with these metrics in view at once, including a forecaster that shows how lifting retention and per-visit contribution moves the bottom line more reliably than adding patients ever does.